| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 04/13/2004 | US6720011 Injectable composition for cancer treatment |
| 04/13/2004 | US6720006 Anti-microbial body care product |
| 04/13/2004 | US6719995 Flexible polybutene strips for preventing gingivitis/whitening of teeth |
| 04/13/2004 | US6719988 Mixture containing solvent, acid; complex |
| 04/13/2004 | US6719987 Sustained release of metal microbiocides |
| 04/13/2004 | US6719963 Liquid oral compositions comprising a calcium compound and an acidulant |
| 04/13/2004 | CA2162877C Monohydrate dextrose or glucose composition |
| 04/08/2004 | WO2004028580A1 Bone-filling composition for stimulating bone-forming and bone-consolidation comprising calcium sulfate and viscous biopolymers |
| 04/08/2004 | WO2004028578A1 Composition for stimulating bone-formation and bone consolidation |
| 04/08/2004 | WO2004028461A2 Antiseptic solutions containing silver chelated with polypectate and edta |
| 04/08/2004 | WO2004009072A3 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| 04/08/2004 | WO2004006833A3 Bowel cleansing composition |
| 04/08/2004 | WO2003099218A3 Anti-cancer formulation |
| 04/08/2004 | WO2003057225A3 Phosphate transport inhibitors |
| 04/08/2004 | US20040068207 Active oxygen generator containing photosensitizer for ultrasonic therapy |
| 04/08/2004 | US20040068005 Pharmaceutical combinations |
| 04/08/2004 | US20040067953 Combination therapy for treating, preventing or managing proliferative disorders and cancers |
| 04/08/2004 | US20040067942 Therapeutic combinations of erb B kinase inhibitors and antineoplastic therapies |
| 04/08/2004 | US20040067586 Comprises viral nucleotide sequences coding protein for treatment of tumors; gene therapy |
| 04/08/2004 | US20040067262 Inhibiting the growth of an inorganic structure in an external auditory canal by flushing with an inorganic matter dissolution solution, such as a hydrochloric acid solution |
| 04/08/2004 | US20040067261 Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof |
| 04/08/2004 | CA2500461A1 Antiseptic solutions containing silver chelated with polypectate and edta |
| 04/08/2004 | CA2500222A1 Bone-filling composition for stimulating bone-forming and bone-consolidation comprising calcium sulfate and viscous biopolymers |
| 04/08/2004 | CA2500220A1 Composition for stimulating bone-formation and bone consolidation |
| 04/07/2004 | EP1404811A2 Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis |
| 04/07/2004 | EP1404346A2 Calcium phosphate delivery vehicles for osteoinductive proteins |
| 04/07/2004 | EP1404334A1 Targeted delivery of bioaffecting compounds for the treatment of cancer |
| 04/07/2004 | EP1404293A1 Infection control system |
| 04/07/2004 | EP1404264A2 Insert for the treatment of dry eye |
| 04/07/2004 | EP1198236A4 Bone graft substitute composition |
| 04/07/2004 | EP1037648B1 The use of erythropoietin and iron preparations for producing pharmaceutical combination preparations for treating rheumatic diseases |
| 04/07/2004 | EP0954289A4 Disinfectant effervescent tablet formulation |
| 04/07/2004 | CN1487853A Cartridges useful in cleaning dialysis solutions |
| 04/07/2004 | CN1487835A Composition of hypochlorous acid and its applications |
| 04/07/2004 | CN1486737A Hepatosis treating Chinese medicine with four integrated functions |
| 04/07/2004 | CN1144598C Stabilization of compositions containing ACE inhibitors using magnesium oxide |
| 04/07/2004 | CN1144594C External-use plaster for softening dry feces and dissipating mass |
| 04/07/2004 | CN1144593C Reagent for diagnosing early urinary culculus |
| 04/07/2004 | CN1144592C Use of camptotheicin derivatives with reduced gastrointestinal toxicity |
| 04/07/2004 | CN1144533C Composite amino-acid calcium compensating agent and its producing method |
| 04/06/2004 | US6716815 Comprises whey/soy protein, casein-polypeptide, fatty acid, and insoluble vegetable/fruit fiber which stimulates cholecystokinin levels for better regulation of glucose and insulin levels following meal consumption; diabetes |
| 04/06/2004 | US6716454 Therapeutic combination of vitamin and calcium in unitary galenic tablet form, a method of obtaining it, and the use thereof |
| 04/01/2004 | WO2004026345A1 Control of nitric oxide bioactivity by perfluorocarbons |
| 04/01/2004 | WO2004026321A1 Methods and compositions for treatment of excess stomach acid in mammals |
| 04/01/2004 | WO2004026289A1 Nutritional or therapeutic compositions |
| 04/01/2004 | WO2004026239A2 Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorption |
| 04/01/2004 | WO2003094933A3 Use of lanthanum for the treatment of hypercalcemia and bone metastasis |
| 04/01/2004 | WO2003081238A3 Cytocapacity test |
| 04/01/2004 | WO2002098852A8 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins |
| 04/01/2004 | WO2002053094A8 Method for detoxifying a carbohydrate containing solution |
| 04/01/2004 | US20040062821 Administration of therapeutic compositions for treating fatigue |
| 04/01/2004 | US20040062820 Administering blend of calcium compound and fat; reducing osteoporosis |
| 04/01/2004 | US20040062818 Composition of hypochlorous acid and its applications |
| 04/01/2004 | US20040062817 Wound healing compound |
| 04/01/2004 | US20040062810 Removal blockage in blood vessels; mixture of angiogenesis inhibitor and polymer |
| 04/01/2004 | US20040062724 Thin, flexible, multilayer film; applying, adhesion to teeth; supplying active materials |
| 04/01/2004 | US20040060865 Buffered compositions for dialysis |
| 04/01/2004 | DE202004000552U1 Mittel zum Bleichen von Zähnen Means for bleaching teeth |
| 04/01/2004 | DE10252929A1 Using sparingly soluble calcium salt for local remineralization of teeth, useful for treating sensitive teeth, also inhibits development of caries |
| 04/01/2004 | CA2539567A1 Nutritional and therapeutic compositions to increase bodily glutathione levels |
| 03/31/2004 | EP1402890A1 Sulfonamide derivatives |
| 03/31/2004 | EP1401833A2 Chemical derivatives and the use thereof as an anti-elomerase agent |
| 03/31/2004 | EP1401791A2 Non-peptidic cyclophilin binding compounds and their use |
| 03/31/2004 | EP1401455A1 Use of a phosphate adsorbent to combat vascular diseases |
| 03/31/2004 | EP1401422A2 Halogenated composition, method for preparing same and uses thereof |
| 03/31/2004 | EP1401407A1 Porous sponge-like cellulosic material for treatment of injuries |
| 03/31/2004 | EP1401297A1 Microbiological control in poultry processing |
| 03/31/2004 | EP1372389A4 Virucidal compositions |
| 03/31/2004 | EP0772445B1 Pharmaceutical compositions, mainly vaginal suppository, containing many different active ingredients |
| 03/31/2004 | EP0740555B1 Preparation of bone for transplantation |
| 03/31/2004 | CN1486194A Colorstrum-based composition |
| 03/31/2004 | CN1486193A Effective antitumour treatments |
| 03/31/2004 | CN1486191A Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors |
| 03/31/2004 | CN1486187A L-histidine in ophthalmic solutions |
| 03/31/2004 | CN1486186A Improved ophthalmic and contact lens solutions containing forms of vitamin B |
| 03/31/2004 | CN1485057A Acne-treating composition |
| 03/31/2004 | CN1485049A Medication composition regulating catecholamine synthesis and release, building up immune function |
| 03/31/2004 | CN1485048A Medication composition facilitating insulin synthesis, enhancing ATP synthesis, improving immune competency< |
| 03/31/2004 | CN1485047A Medication composition nourishing yin and clearing away heat, facilitating Ach synthesis, building up immune competency |
| 03/31/2004 | CN1485046A Medication composition replenishing qi and blood, facilitating ATP synthesis, building up immune competency |
| 03/31/2004 | CN1485045A Medication composition dispelling wind, facilitating ATP synthesis, building up immune competency |
| 03/31/2004 | CN1485026A Intravenous injection liquid preparing method of oxygen-enriched broad transfusion |
| 03/31/2004 | CN1143690C Silicate-containing powders providing controlled, sustained gas release |
| 03/31/2004 | CN1143685C Pterygium eliminating liquid |
| 03/31/2004 | CN1143673C Improvement in the taste of active pharmaceutical ingredients |
| 03/30/2004 | US6713517 Using n-(2-diethylamino-ethyl)-4-amino-3-chlorobenzamide |
| 03/30/2004 | US6713089 Under acidic conditions; nonsteroid antiinflammatory nsaid; crushing strength |
| 03/25/2004 | WO2004024226A1 Device for delivering a viscous medical solution to the nasal membrane and method for using same |
| 03/25/2004 | WO2004024225A1 System and method for delivering a composition to the nasal membrane |
| 03/25/2004 | WO2004024197A1 Wound dressing materials comprising complexes of anionic polysaccharides with silver |
| 03/25/2004 | WO2004024166A1 Method for preventing or reducing secondary fractures after hip fracture |
| 03/25/2004 | WO2004023899A1 Human and/or animal fiber-water including encapsulated additives having specific dietary and medical uses |
| 03/25/2004 | WO2004004638A3 Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects |
| 03/25/2004 | WO2003068200A3 Novel therapeutic application for a composition |
| 03/25/2004 | WO2002089832A3 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio. |
| 03/25/2004 | US20040060077 Using dietary restriction to lower serum insulin levels and function as tool in treatment and prevention of alzheimer's diseases |
| 03/25/2004 | US20040058889 Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorption |
| 03/25/2004 | US20040058873 Method for treating or preventing Alzheimer's disease |
| 03/25/2004 | US20040058855 Use of materials having zinc ionophoric behavior |
| 03/25/2004 | US20040058024 Comprises polyunsaturated fatty acid-containing composition extracted from Echium plants, with antilipemic agents, antioxidants, and antidiabetic agents, for formulation as dietary supplement |